— Know what they know.
Not Investment Advice
Also trades as: GMAB.CO (CPH) · $vol 55M · GNMSF (OTC) · $vol 1M · GE9.F (FSX) · $vol 0M

GMAB NASDAQ

Genmab A/S
1W: +16.1% 1M: +26.5% 3M: +54.1% YTD: +40.5% 1Y: +49.6% 3Y: +56.0% 5Y: +0.4%
$44.67
-0.01 (-0.03%)
After Hours: $44.30 (-0.37, -0.83%)
Weekly Expected Move ±8.1%
$37 $40 $44 $47 $51
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Buy · Power 70 · $27.5B mcap · 587M float · 0.486% daily turnover · Short 61% of daily vol
Credit Risk of going bust: lower than 69% of companies Debt: 16.1% of company value Bonds: $301.5M held by 241 funds, 181 bp over Treasuries → details ▾
If the stock fell to about $0.65 (down 99%), Genmab A/S would be worth roughly what it owes.
Total debt $5.27B against a stock market value of $27.48B.
Distance to default 7.47 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $2.71B (short-term plus half of long-term), stock volatility 35.1%; Altman Z'' 3.61. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
39.8 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 11.9%  ·  5Y Avg: 15.7%
Cost Advantage ★
53
Intangibles
33
Switching Cost
26
Network Effect
47
Scale
49
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. GMAB has No discernible competitive edge (39.8/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. ROIC of 11.9% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$42
Low
$51
Avg Target
$58
High
Based on 3 analysts since Aug 6, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 14Hold: 3Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$51.33
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-20 Morgan Stanley Sean Laaman $31 $42 +11 +9.1% $38.50
2026-10-07 Guggenheim Michael Schmidt $54 $58 +4 +53.4% $37.80
2026-10-05 Guggenheim Michael Schmidt $40 $54 +14 +55.4% $34.75
2026-07-22 New Street — Initiated $43 — +51.6% $28.36
2026-05-27 Truist Financial Gregory Renza $48 $40 -8 +48.8% $26.89
2026-04-30 H.C. Wainwright — $39 $38 -1 +45.5% $26.11
2026-03-26 Wolfe Research — Initiated $32 — +22.9% $26.03
2026-02-23 Guggenheim Michael Schmidt $43 $40 -3 +36.6% $29.29
2026-02-17 Jefferies Benjamin Jackson Initiated $42 — +38.2% $30.03
2026-01-20 H.C. Wainwright — $40 $39 -1 +20.9% $32.25
2025-11-06 Truist Financial Asthika Goonewardene $49 $48 -1 +66.4% $28.84
2025-10-06 Truist Financial Asthika Goonewardene $45 $49 +4 +46.0% $33.56
2025-10-02 H.C. Wainwright — $50 $40 -10 +25.9% $31.77
2025-09-29 Leerink Partners Jonathan Chang $36 $34 -2 +16.6% $29.16
2025-09-23 Guggenheim Michael Schmidt Initiated $43 — +50.3% $28.60
2025-03-11 Truist Financial Asthika Goonewardene $53 $45 -8 +122.1% $20.26
2024-09-03 Morgan Stanley Vikram Purohit $34 $31 -3 +13.1% $27.41
2024-08-09 BMO Capital Etzer Darout $48 $46 -2 +69.9% $27.07
2024-06-27 BTIG Kaveri Pohlman Initiated $47 — +83.1% $25.67
2024-06-27 H.C. Wainwright Raghuram Selvaraju Initiated $50 — +94.5% $25.71
2024-06-04 Truist Financial Asthika Goonewardene Initiated $53 — +83.8% $28.83
2024-02-23 BMO Capital Etzer Darout Initiated $48 — +64.6% $29.16
2023-02-05 Leerink Partners — Initiated $36 — -5.9% $38.26
2022-11-28 Morgan Stanley Matthew Harrison Initiated $34 — -24.2% $44.83
2022-05-02 Cowen & Co. — Initiated $38 — +8.9% $34.91

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 27, 2026
DCF
3
ROE
4
ROA
4
D/E
1
P/E
2
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. GMAB receives an overall rating of B. Strongest factors: ROE (4/5), ROA (4/5). Areas of concern: D/E (1/5), P/E (2/5).
Rating Change History
DateFromTo
2026-10-26 B+ B
2026-10-12 B B+
2026-06-02 B+ B
2026-05-11 A- B+
2026-04-24 B+ A-
2026-04-01 B B+
2026-02-23 A+ B
2026-01-22 A A+
2026-01-03 A- A

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 40 Grade B
Profitability
66
Balance Sheet
56
Earnings Quality
71
Growth
0
Value
54
Momentum
36
Safety
65
Cash Flow
52
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. GMAB scores highest in Earnings Quality (71/100) and lowest in Growth (0/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.84
Grey Zone
Piotroski F-Score
4/9
✓ ✓ ✗ ✓ ✗ ✗ ✓ ✗ ✗
Beneish M-Score
-3.51
Unlikely Manipulator
Ohlson O-Score
-7.76
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB+
Score: 64.0/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 1.13x
Accruals: -0.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. GMAB scores 2.84, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. GMAB scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. GMAB's score of -3.51 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. GMAB's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. GMAB receives an estimated rating of BBB+ (score: 64.0/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). GMAB's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
34.89x
PEG
-0.41x
P/S
2.85x
P/B
4.60x
P/FCF
19.54x
P/OCF
19.04x
EV/EBITDA
16.99x
EV/Revenue
5.02x
EV/EBIT
17.63x
EV/FCF
23.89x
Earnings Yield
4.65%
FCF Yield
5.12%
Shareholder Yield
0.71%
Graham Number
$16.65
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 34.9x earnings, GMAB commands a growth premium. Graham's intrinsic value formula yields $16.65 per share, 168% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.870
NI / EBT
×
Interest Burden
0.771
EBT / EBIT
×
EBIT Margin
0.285
EBIT / Rev
×
Asset Turnover
0.154
Rev / Assets
×
Equity Multiplier
1.352
Assets / Equity
=
ROE
4.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. GMAB's ROE of 4.0% is driven by a balanced combination of operating margin, asset efficiency, and leverage.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$10.86
Price/Value
2.53x
Margin of Safety
-153.06%
Premium
153.06%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with GMAB's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. GMAB trades at a 153% premium to its adjusted intrinsic value of $10.86, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 34.9x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$44.67
Median 1Y
$47.03
5th Pctile
$27.15
95th Pctile
$81.56
Ann. Volatility
35.0%
Analyst Target
$51.33
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
3,029
+12.9% YoY
Revenue / Employee
$7,833,631
Rev: $23,728,068,019
Profit / Employee
$2,027,900
NI: $6,142,507,928
SGA / Employee
$1,267,700
Avg labor cost proxy
R&D / Employee
$3,282,965
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 14.5% 14.6% 11.1% 17.7% 23.6% 22.0% 20.8% 17.4% 14.4% 14.6% 14.3% 10.5% 7.3% 16.1% 16.7% 23.0% 34.9% 7.5% 13.3% 4.0% 3.98%
ROA 12.6% 13.1% 10.1% 15.9% 20.7% 19.9% 18.8% 15.6% 12.6% 13.1% 12.7% 8.9% 6.1% 13.6% 14.2% 18.7% 28.1% 4.3% 9.8% 2.9% 2.95%
ROIC 83.7% 69.4% 71.5% 74.8% 99.1% 88.6% 1.4% 1.1% 1.1% 95.3% 97.1% 17.2% 19.0% 26.0% 27.2% 37.5% 1.9% 4.1% 26.8% 11.9% 11.93%
ROCE 17.8% 18.9% 15.0% 15.7% 17.2% 22.6% 21.8% 21.4% 22.2% 16.8% 15.7% 12.2% 10.3% 12.2% 13.4% 19.9% 91.4% 4.9% 31.3% 10.3% 10.33%
Gross Margin 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 99.5% 98.3% 97.3% 95.5% 96.4% 95.1% 94.8% 94.1% 93.8% 94.3% 92.3% 92.7% 92.7% 92.73%
Operating Margin 38.5% 30.9% 24.3% 39.4% 47.2% 50.1% 14.7% 35.2% 35.8% 35.7% 19.2% 30.3% 37.9% 33.5% 26.3% 38.9% 44.9% 23.0% 25.1% 35.2% 35.24%
Net Margin 38.5% 27.3% 21.9% 59.8% 63.2% 10.0% 7.4% 32.0% 44.7% 13.7% 31.8% 26.1% 22.9% 59.7% 27.3% 36.3% 39.2% 2.9% 5.9% 26.2% 26.23%
EBITDA Margin 53.4% 39.4% 32.0% 41.4% 48.8% 51.9% 16.6% 36.5% 58.7% 21.2% 44.1% 41.6% 39.8% 36.6% 37.1% 48.4% 49.2% 9.4% 20.8% 37.3% 37.32%
FCF Margin 12.0% 23.3% 15.0% 19.2% 29.0% 24.8% 40.7% 34.8% 33.8% 42.8% 28.9% 36.9% 34.7% 20.3% 31.5% 23.5% 20.7% 33.5% 13.0% 21.0% 21.00%
OCF Margin 15.0% 26.3% 18.1% 21.9% 31.3% 27.0% 43.1% 37.2% 36.2% 45.0% 30.8% 38.5% 35.7% 20.9% 33.6% 25.3% 22.8% 36.7% 13.9% 21.6% 21.55%
ROE 3Y Avg snapshot only 15.17%
ROE 5Y Avg snapshot only 15.56%
ROA 3Y Avg snapshot only 10.86%
ROIC 3Y Avg snapshot only 13.54%
ROIC Economic snapshot only 10.41%
Cash ROA snapshot only 7.11%
Cash ROIC snapshot only 9.15%
CROIC snapshot only 8.92%
NOPAT Margin snapshot only 28.09%
Pretax Margin snapshot only 21.93%
R&D / Revenue snapshot only 43.14%
SGA / Revenue snapshot only 17.60%
SBC / Revenue snapshot only 1.72%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio — — — — — — — — — — — — — — — — 2.90 7.52 6.55 21.51 34.894
P/S Ratio — — — — — — — — — — — — — — — — 1.36 2.39 1.94 4.10 2.848
P/B Ratio — — — — — — — — — — — — — — — — 3.31 0.56 3.02 2.85 4.599
P/FCF — — — — — — — — — — — — — — — — 6.54 7.15 14.91 19.54 19.545
P/OCF — — — — — — — — — — — — — — — — 5.94 6.52 13.90 19.04 19.040
EV/EBITDA — — — — — — — — — — — — — — — — 2.64 12.19 5.78 16.99 16.994
EV/Revenue — — — — — — — — — — — — — — — — 1.12 5.22 2.37 5.02 5.016
EV/EBIT — — — — — — — — — — — — — — — — 2.75 12.65 5.98 17.63 17.630
EV/FCF — — — — — — — — — — — — — — — — 5.42 15.59 18.25 23.89 23.891
Earnings Yield — — — — — — — — — — — — — — — — 34.5% 13.3% 15.3% 4.6% 4.65%
FCF Yield — — — — — — — — — — — — — — — — 15.3% 14.0% 6.7% 5.1% 5.12%
EV/OCF snapshot only 23.274
EV/Gross Profit snapshot only 5.392
Acquirers Multiple snapshot only 15.533
Shareholder Yield snapshot only 0.71%
Graham Number snapshot only $16.65
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 12.00 14.50 17.31 13.11 9.62 15.48 14.44 14.93 11.38 13.34 12.46 5.03 5.17 5.25 6.22 6.22 6.03 2.02 2.18 2.46 2.457
Quick Ratio 12.00 14.50 17.31 13.11 9.62 15.48 14.44 14.90 11.36 13.32 12.42 5.02 5.15 5.24 6.20 6.20 6.01 2.01 2.17 2.44 2.441
Debt/Equity 0.02 0.02 0.02 0.03 0.02 0.02 0.03 0.03 0.03 0.02 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.95 0.94 0.89 0.885
Net Debt/Equity -0.86 -0.85 -0.86 -0.86 -0.87 -0.80 -0.87 -0.84 -0.86 -0.87 -0.88 -0.48 -0.51 -0.55 -0.52 -0.52 -0.57 0.66 0.67 0.63 0.633
Debt/Assets 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.02 0.02 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.43 0.43 0.42 0.421
Debt/EBITDA 0.10 0.09 0.11 0.15 0.13 0.09 0.13 0.12 0.11 0.13 0.18 0.23 0.26 0.20 0.18 0.12 0.02 9.54 1.48 4.32 4.324
Net Debt/EBITDA -4.39 -4.12 -5.17 -4.94 -4.62 -3.27 -3.68 -3.62 -3.60 -4.76 -5.15 -3.39 -4.31 -3.90 -3.39 -2.27 -0.55 6.60 1.06 3.09 3.092
Interest Coverage 8.96 9.90 8.04 235.71 250.68 305.10 269.91 267.88 276.04 203.56 213.28 112.81 76.89 52.09 51.51 55.01 48.21 32.78 16.22 4.36 4.365
Equity Multiplier 1.13 1.11 1.10 1.12 1.15 1.10 1.12 1.11 1.13 1.12 1.13 1.25 1.24 1.25 1.22 1.22 1.22 2.20 2.18 2.10 2.101
Cash Ratio snapshot only 1.318
Debt Service Coverage snapshot only 4.528
Cash to Debt snapshot only 0.285
FCF to Debt snapshot only 0.164
Defensive Interval snapshot only 404.9 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.35 0.37 0.38 0.41 0.44 0.53 0.55 0.55 0.51 0.50 0.42 0.31 0.31 0.33 0.35 0.47 0.60 0.14 0.33 0.15 0.154
Inventory Turnover — — — — — — — 0.82 2.86 7.93 4.77 5.98 6.44 11.18 7.22 17.12 18.78 6.14 10.93 5.74 5.738
Receivables Turnover 3.01 2.91 3.84 3.24 2.94 3.20 5.04 3.79 3.25 3.08 3.60 1.98 1.98 2.32 2.45 2.97 3.82 1.27 2.42 1.10 1.096
Payables Turnover — 0.00 — — — 0.00 — — — — — — — — — — — 0.16 1.31 — —
DSO 121 125 95 113 124 114 72 96 112 119 102 184 185 158 149 123 96 288 151 333 332.9 days
DIO — — — — — — — 443 128 46 76 61 57 33 51 21 19 59 33 64 63.6 days
DPO — — — — — — — 0 0 0 0 0 0 0 0 0 0 2289 278 0 —
Cash Conversion Cycle — — — — — — — 540 240 165 178 245 241 190 200 144 115 -1942 -94 397 —
Fixed Asset Turnover snapshot only 16.264
Operating Cycle snapshot only 396.5 days
Cash Velocity snapshot only 2.749
Capital Intensity snapshot only 3.029
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue -28.3% -16.1% -16.5% 39.5% 51.6% 71.0% 68.7% 58.9% 40.6% 13.0% -7.0% -33.6% -31.2% -18.5% -4.9% 72.3% 21.0% -35.2% -34.4% -77.7% -77.74%
Net Income -49.1% -36.8% -57.4% 57.7% 96.8% 81.2% 1.2% 17.1% -26.4% -21.3% -17.8% -32.4% -44.7% 28.4% 29.0% 1.4% 1.9% -49.9% -52.5% -89.4% -89.40%
EPS -49.3% -36.8% -57.4% 57.6% 97.3% 81.4% 1.2% 17.4% -26.3% -21.0% -17.6% -31.4% -43.9% 31.6% 32.5% 1.5% 2.0% -52.3% -52.5% -89.4% -89.35%
FCF -86.7% -67.7% -75.1% -65.0% 2.7% 81.9% 3.6% 1.9% 63.7% 95.1% -33.9% -29.6% -29.4% -61.3% 3.6% 9.7% -27.6% 6.7% -72.9% -80.1% -80.11%
EBITDA -50.0% -34.0% -53.0% -2.7% 20.1% 44.7% 70.1% 56.5% 48.2% -13.5% -13.9% -34.7% -49.0% -10.4% -7.1% 76.3% 57.5% -28.0% -29.5% -84.1% -84.09%
Op. Income -59.3% -52.2% -55.7% 12.9% 45.4% 1.1% 1.1% 84.7% 36.5% -16.4% -20.0% -42.0% -32.9% -11.9% -5.1% 81.6% 23.4% -31.3% -31.5% -80.2% -80.18%
OCF Growth snapshot only -81.07%
Asset Growth snapshot only -69.45%
Equity Growth snapshot only -82.27%
Debt Growth snapshot only 4.62%
Shares Change snapshot only -0.45%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 41.2% 41.0% 45.4% 47.2% 48.8% 39.3% 39.0% 16.2% 15.2% 17.5% 9.5% 13.7% 13.6% 16.4% 14.3% 22.0% 5.4% -15.8% -16.6% -36.6% -36.62%
Revenue 5Y 40.1% 36.1% 36.6% 34.5% 39.4% 43.7% 40.3% 45.0% 43.1% 40.2% 37.0% 27.5% 26.1% 20.0% 18.9% 12.4% 4.9% -3.1% -3.9% -10.8% -10.81%
EPS 3Y 23.7% 24.3% 18.1% 47.8% 53.8% 35.8% 30.0% -6.4% -9.7% -3.3% -8.4% 8.3% -6.6% 23.6% 33.7% 25.9% 7.3% -20.8% -19.7% -43.4% -43.41%
EPS 5Y 29.6% 18.8% 12.9% 22.5% 36.1% 36.0% 30.7% 28.6% 22.4% 22.4% 24.4% 21.1% 8.5% 21.1% 19.1% 6.9% 4.3% -10.7% -13.5% -19.6% -19.64%
Net Income 3Y 26.4% 26.9% 20.9% 50.2% 54.7% 36.0% 30.0% -6.4% -9.7% -3.4% -8.6% 7.7% -7.1% 22.3% 32.3% 23.3% 5.1% -20.3% -20.5% -44.6% -44.62%
Net Income 5Y 31.3% 20.4% 14.4% 24.0% 37.3% 37.6% 32.2% 30.2% 23.9% 23.8% 26.0% 21.8% 8.5% 20.5% 18.4% 5.6% 3.1% -10.3% -14.1% -20.7% -20.70%
EBITDA 3Y 48.4% 48.4% 44.9% 49.6% 41.6% 30.8% 25.4% -4.5% -3.8% -6.2% -11.7% -0.2% -3.2% 3.9% 10.8% 21.7% 6.0% -17.7% -17.4% -43.2% -43.20%
EBITDA 5Y 42.6% 32.8% 27.1% 25.2% 31.9% 42.5% 36.3% 42.7% 42.2% 32.5% 34.8% 27.9% 16.5% 11.6% 9.5% 0.1% -6.5% -11.8% -14.7% -22.5% -22.52%
Gross Profit 3Y 41.2% 41.0% 45.4% 47.2% 48.8% 39.3% 39.0% 16.1% 15.0% 16.9% 8.8% 12.8% 12.1% 14.4% 12.4% 19.8% 3.4% -17.6% -18.4% -38.1% -38.10%
Gross Profit 5Y 40.1% 36.1% 36.6% 34.5% 39.4% 43.7% 40.3% 45.0% 42.9% 39.8% 36.5% 26.9% 25.1% 18.8% 17.7% 11.1% 3.7% -4.3% -5.2% -12.1% -12.09%
Op. Income 3Y 31.5% 29.8% 42.8% 49.7% 56.1% 33.4% 31.1% -3.4% -6.8% -6.0% -10.0% 6.6% 10.0% 15.2% 16.0% 24.8% 4.2% -20.3% -19.6% -40.7% -40.68%
Op. Income 5Y 33.9% 23.4% 22.6% 18.6% 27.3% 36.1% 30.6% 39.2% 35.2% 30.6% 36.8% 29.1% 28.4% 11.8% 11.4% -1.0% -7.7% -12.9% -13.9% -15.3% -15.32%
FCF 3Y 17.5% 54.3% 22.8% 35.9% 40.6% 43.2% 36.2% 33.4% -7.2% 4.6% -8.9% -10.9% 61.9% 11.2% 46.5% 30.5% -5.8% -6.9% -43.0% -46.4% -46.44%
FCF 5Y 8.4% 46.3% 5.0% 7.7% 24.4% 19.1% 39.1% 48.0% 57.7% 67.2% 41.3% 38.4% 26.3% 17.3% 11.6% 12.9% -16.4% -13.9% -26.7% -31.2% -31.16%
OCF 3Y 3.8% 30.0% 10.8% 21.4% 40.5% 43.4% 36.3% 31.6% -6.2% 4.7% -8.5% -10.7% 51.6% 7.9% 40.6% 28.2% -5.1% -6.7% -42.7% -47.2% -47.17%
OCF 5Y 12.6% 46.7% 8.4% 9.4% 24.4% 19.7% 38.2% 46.6% 41.9% 48.7% 29.5% 27.1% 25.0% 16.1% 11.8% 12.2% -15.4% -13.1% -26.4% -31.3% -31.30%
Assets 3Y 48.0% 42.8% 41.8% 45.2% 32.0% 25.8% 1.4% 15.6% 17.9% 18.6% 18.2% 19.8% 18.3% 23.0% 18.0% 14.2% -38.8% 39.6% -25.9% -26.9% -26.85%
Assets 5Y 40.7% 36.3% 35.7% 35.4% 39.1% 35.5% 35.0% 34.7% 36.6% 33.1% 33.2% 33.9% 24.4% 24.8% 78.7% 14.6% -20.1% 31.1% -11.0% -11.1% -11.06%
Equity 3Y 44.3% 40.4% 40.9% 43.5% 28.7% 24.8% 1.3% 17.2% 19.0% 18.2% 17.4% 15.2% 14.5% 18.2% 13.9% 11.1% -40.0% 10.9% -40.7% -40.8% -40.83%
Book Value 3Y 41.3% 37.5% 37.7% 41.3% 28.0% 24.6% 1.3% 17.1% 19.0% 18.4% 17.6% 15.8% 15.2% 19.5% 15.1% 13.5% -38.8% 10.2% -40.1% -39.5% -39.54%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.67 0.81 0.80 0.69 0.75 0.87 0.86 0.79 0.83 0.91 0.84 0.68 0.69 0.74 0.74 0.44 0.18 0.00 0.04 0.00 0.000
Earnings Stability 0.51 0.62 0.40 0.39 0.62 0.76 0.53 0.41 0.42 0.58 0.38 0.08 0.00 0.49 0.27 0.12 0.00 0.03 0.06 0.00 0.000
Margin Stability 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.99 0.99 0.99 0.98 0.98 0.98 0.98 0.97 0.97 0.97 0.97 0.968
Rev. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.80 0.85 0.50 0.50 0.50 0.50 0.50 0.93 0.89 0.91 0.93 0.87 0.82 0.89 0.88 0.50 0.50 0.80 0.50 0.50 0.500
Earnings Smoothness 0.35 0.55 0.19 0.55 0.35 0.42 0.26 0.84 0.70 0.76 0.80 0.61 0.42 0.75 0.75 0.19 0.04 0.33 0.29 0.00 0.000
ROE Trend -0.08 -0.07 -0.59 -0.06 -0.01 0.01 -0.00 0.02 -0.04 -0.03 -0.02 -0.06 -0.10 -0.02 0.00 0.09 1.04 -0.07 0.31 -0.03 -0.029
Gross Margin Trend 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.00 -0.01 -0.01 -0.02 -0.02 -0.04 -0.04 -0.04 -0.04 -0.03 -0.03 -0.03 -0.03 -0.030
FCF Margin Trend -0.38 -0.18 -0.32 -0.31 -0.09 -0.17 0.08 -0.13 0.13 0.19 0.01 0.10 0.03 -0.13 -0.03 -0.12 -0.14 0.02 -0.17 -0.09 -0.092
Sustainable Growth Rate 14.5% 14.6% 11.1% 17.7% 23.6% 22.0% 20.8% 17.4% 14.4% 14.6% 14.3% 10.5% 7.3% 16.1% 16.7% 23.0% 34.9% 7.5% 13.3% 4.0% 3.98%
Internal Growth Rate 14.5% 15.1% 11.2% 18.9% 26.1% 24.9% 23.1% 18.5% 14.5% 15.1% 14.6% 9.8% 6.5% 15.7% 16.5% 23.0% 39.2% 4.5% 10.9% 3.0% 3.04%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.41 0.74 0.69 0.56 0.66 0.72 1.26 1.30 1.47 1.72 1.02 1.32 1.80 0.51 0.82 0.63 0.49 1.15 0.47 1.13 1.130
FCF/OCF 0.80 0.89 0.83 0.88 0.93 0.92 0.94 0.93 0.93 0.95 0.94 0.96 0.97 0.97 0.94 0.93 0.91 0.91 0.93 0.97 0.974
FCF/Net Income snapshot only 1.101
OCF/EBITDA snapshot only 0.730
CapEx/Revenue 3.1% 3.0% 3.1% 2.6% 2.3% 2.2% 2.4% 2.4% 2.4% 2.2% 1.9% 1.6% 1.1% 0.6% 2.1% 1.8% 2.1% 3.3% 0.9% 0.6% 0.56%
CapEx/Depreciation snapshot only 0.523
Accruals Ratio 0.07 0.03 0.03 0.07 0.07 0.06 -0.05 -0.05 -0.06 -0.09 -0.00 -0.03 -0.05 0.07 0.03 0.07 0.14 -0.01 0.05 -0.00 -0.004
Sloan Accruals snapshot only -0.717
Cash Flow Adequacy snapshot only 38.703
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield — — — — — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 17.2% 16.5% 14.0% 7.4% 17.3% 18.0% 29.7% 29.4% 16.1% 15.6% 2.9% 16.8% 35.5% 14.0% 22.8% 45.6% 47.5% 1.1% 1.0% 15.2% 15.22%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — — 16.4% 15.2% 15.7% 0.7% 0.71%
Net Buyback Yield — — — — — — — — — — — — — — — — 16.4% 15.2% 15.7% 0.6% 0.65%
Total Shareholder Return — — — — — — — — — — — — — — — — 16.4% 15.2% 15.7% 0.6% 0.65%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.81 0.76 0.75 0.76 0.77 0.79 0.79 0.80 0.80 0.77 0.77 0.76 0.72 0.94 0.94 0.90 0.94 0.80 0.79 0.87 0.870
Interest Burden (EBT/EBIT) 0.90 0.91 0.89 1.31 1.54 1.08 1.06 0.90 0.72 1.01 1.04 0.99 0.89 1.19 1.19 1.12 1.22 0.97 0.94 0.77 0.771
EBIT Margin 0.50 0.51 0.39 0.39 0.40 0.44 0.41 0.40 0.43 0.34 0.38 0.39 0.31 0.37 0.37 0.40 0.41 0.41 0.40 0.28 0.285
Asset Turnover 0.35 0.37 0.38 0.41 0.44 0.53 0.55 0.55 0.51 0.50 0.42 0.31 0.31 0.33 0.35 0.47 0.60 0.14 0.33 0.15 0.154
Equity Multiplier 1.14 1.11 1.10 1.12 1.14 1.11 1.11 1.12 1.14 1.11 1.12 1.18 1.19 1.19 1.17 1.23 1.24 1.73 1.36 1.35 1.352
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $4.35 $4.55 $3.60 $6.00 $8.58 $8.25 $7.89 $7.05 $6.32 $6.52 $6.50 $4.84 $3.55 $8.58 $8.62 $11.99 $10.58 $4.10 $4.09 $1.28 $1.28
Book Value/Share $32.21 $33.56 $34.45 $37.11 $40.44 $41.29 $41.30 $43.67 $47.23 $48.05 $49.49 $47.73 $49.20 $57.20 $52.55 $54.20 $9.26 $55.28 $8.90 $9.65 $9.71
Tangible Book/Share $31.80 $33.17 $34.09 $36.78 $40.14 $41.07 $41.10 $43.48 $47.06 $47.90 $49.46 $25.34 $27.76 $34.01 $31.67 $32.66 $5.88 $-34.33 $-5.67 $-5.30 $-5.30
Revenue/Share $11.97 $12.82 $13.68 $15.47 $18.18 $21.95 $23.12 $24.65 $25.58 $24.92 $21.57 $16.60 $17.88 $20.83 $21.08 $29.94 $22.62 $12.87 $13.84 $6.69 $15.72
FCF/Share $1.43 $2.99 $2.05 $2.98 $5.28 $5.44 $9.41 $8.57 $8.65 $10.66 $6.24 $6.12 $6.20 $4.23 $6.64 $7.03 $4.69 $4.31 $1.80 $1.41 $1.42
OCF/Share $1.80 $3.37 $2.47 $3.39 $5.70 $5.92 $9.96 $9.17 $9.27 $11.22 $6.65 $6.39 $6.39 $4.36 $7.08 $7.59 $5.16 $4.73 $1.93 $1.44 $1.46
Cash/Share $28.37 $29.24 $30.30 $32.76 $36.09 $33.79 $37.28 $37.79 $41.78 $42.77 $45.06 $24.25 $26.69 $32.89 $28.73 $29.63 $5.50 $16.21 $2.38 $2.44 $2.45
EBITDA/Share $6.32 $6.94 $5.74 $6.44 $7.60 $10.06 $9.78 $10.10 $11.27 $8.74 $8.44 $6.70 $5.83 $8.03 $8.05 $12.36 $9.60 $5.51 $5.68 $1.98 $1.98
Debt/Share $0.66 $0.64 $0.63 $0.96 $0.95 $0.90 $1.26 $1.22 $1.20 $1.17 $1.54 $1.57 $1.52 $1.60 $1.47 $1.51 $0.23 $52.57 $8.38 $8.54 $8.54
Net Debt/Share $-27.71 $-28.59 $-29.67 $-31.80 $-35.13 $-32.88 $-36.02 $-36.57 $-40.58 $-41.60 $-43.52 $-22.68 $-25.17 $-31.29 $-27.27 $-28.12 $-5.27 $36.35 $6.00 $6.11 $6.11
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 2.845
Altman Z-Prime snapshot only 5.368
Piotroski F-Score 3 2 5 4 5 6 6 7 6 5 4 4 4 4 5 7 7 3 4 4 4
Beneish M-Score -1.85 -2.31 -2.20 -1.89 -1.59 -1.47 -2.46 -2.38 -2.70 -3.05 2.15 10.22 6.20 8.62 9.16 2.87 -2.60 2.52 -2.80 -3.51 -3.508
Ohlson O-Score snapshot only -7.759
Net-Net WC snapshot only $-6.09
EVA snapshot only $187655939.25
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB+
Credit Score 77.42 78.06 78.53 83.13 83.24 83.83 83.20 83.36 83.59 83.54 83.52 83.47 83.37 83.12 83.09 83.10 96.67 53.63 87.40 64.03 64.027
Credit Grade snapshot only 8
Credit Trend snapshot only -19.072
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 62
Sector Credit Rank snapshot only 57

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms